Leerink Partners Raises Price target on Neurocrine Biosciences (NBIX) Following Positive KINECT3 Results
Go back to Leerink Partners Raises Price target on Neurocrine Biosciences (NBIX) Following Positive KINECT3 Results| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 157.73 +1.51 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.22 | 52 Week High | $58.46 | |||
| Open | $158.00 | 52 Week Low | $31.25 | |||
| Day High | $159.19 | P/E | N/A | |||
| Day Low | $156.57 | EPS | $-0.69 | |||
| Volume | 303,030 | |||||
